# Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures
Canonical URL: https://biopharmsignal.com/news/BNGO/bionano-announces-full-retirement-of-outstanding-senior-secured-convertible-debentures
Ticker: BNGO
Company: BioNano Genomics
Source: BioNano Genomics
Published: 2026-06-25 13:46 EST
Original Source URL: https://ir.bionanogenomics.com
## Summary

SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has fully retired and cancelled all outstanding Senior Secured Convertible Debentures (the "Debentures"). The Company used cash on hand to retire the Debentures, which were originally issued in

## Article Body
SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has fully retired and cancelled all outstanding Senior Secured Convertible Debentures (the "Debentures"). The Company used cash on hand to retire the Debentures, which were originally issued in
## Recent Company News
- 2026-06-25 13:46 EST — [Bionano Announces Hiring of Chief Scientific Officer](https://biopharmsignal.com/news/BNGO/bionano-announces-hiring-of-chief-scientific-officer) — Source: BioNano Genomics
- 2026-06-25 13:46 EST — [Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption](https://biopharmsignal.com/news/BNGO/bionano-announces-67-year-over-year-growth-in-studies-featuring-optical-genome-mapping-at-eshg-2026-reflecting-expanding-global-adoption) — Source: BioNano Genomics
- 2026-06-25 13:46 EST — [Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders](https://biopharmsignal.com/news/BNGO/bionano-announces-multiple-publications-in-2026-describing-unique-utility-of-ogm-in-studies-of-reproductive-health-and-prenatal-genetic-disorders) — Source: BioNano Genomics
- 2026-06-25 13:46 EST — [Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures](https://biopharmsignal.com/news/BNGO/bionano-announces-full-retirement-of-outstanding-senior-secured-convertible-debentures) — Source: BioNano Genomics
- 2026-06-25 13:46 EST — [Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia](https://biopharmsignal.com/news/BNGO/bionano-announces-largest-ogm-study-of-t-cell-acute-lymphoblastic-leukemia) — Source: BioNano Genomics
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)